Different reasons to mark the date

VALENTINE’S Day will always have a special place in the heart of Bendigo State Emergency Service volunteer Natalie Stanway. In 2012, as millions around the world celebrated the annual day of romance, Mrs Stanway was undergoing tests that would confirm she had breast cancer.

Will Seattle Genetics’ Deal With Immunomedics Get Scuttled?

The deal could be a big win for Seattle Genetics, but it doesn’t have the full support of all of Immunomedics investors. After the closing market bell on Friday, venBio Select Advisors, LLC — the beneficial owner of 9.9% of Immunomedics shares — said Immunomedics’ board of directors is “giving away its crown jewel.”

Children also battle cancer – Matilda Obiajunwa

WORLD Cancer Day was celebrated on February 4. On that day, everybody seemed to be talking about all the different cancers from the most common which is breast cancer to prostrate cancer and without attention paid to childhood cancer. As bad and tragic as it sounds, cancer affects everybody, including a baby born today.

Radiotherapy Market Research Insights, Intended Audience, Regional…

Synopsis of Radiotherapy Market Market Segmentation: Global Radiotherapy Market has been segmented as follows: -On the basis of Types which comprises of external beam radiation therapy, internal radiation therapy, systemic radiation therapy and others and others -On the basis of End Users which consists of hospitals, clinics, research facilities and others.

Beware! Dense breasts doubles risk of cancer: Study

Washington D.C. [USA], Feb. 10 : Beware! A study finds that women with dense breasts have two-fold increased risk of developing breast cancer. The study, published in the journal Cancer, is among the first to find the association between breast density and contralateral breast cancer .

Montgomery woman thanks LifeSouth for saving her life

Jenny Dodson said she is “glad” she was diagnosed with stage three breast cancer last year because it required her to lean on her faith and gave her a testimony. Now, that she is cancer-free and just celebrated her one year anniversary with her husband, Rad, she says her future is bright.

Breast cancer treatment to start within weeks

Radiotherapy treatment for breast cancer patients at the North West Cancer Centre will begin within weeks, it has been confirmed. Andrew Reilly, Head of Physics at the North West Cancer Services, said that the treatment of head and neck, bladder and rectum cancers and a range of palliative therapies are also expected to be fully operational by mid-summer.

Del Grou with his beard that he grew for more than a year

A High Wycombe man raised more than A 1,000 for a cancer charity, smashing his A 600 target, by growing his beard for more than a year. Del Grou, 44, who is originally from Marlow, decided he was going to grow his beard last January for Cancer Research, after three members of his family – his wife, brother and aunt – were diagnosed with the disease.

Chichester cancer nurse to cycle from London to Paris for Myeloma UK

The drugs and treatment options available now were not available then, and new advances in the treatment of Myeloma are being made all the time. Rusty said: “”As a cancer nurse working at the Fernhurst Centre at St Richards Hospital, I see patients with this blood disease receiving drugs that can offer a better quality of life and much longer remission times than a few years ago.

A new tool to help breast cancer patients

A free decision making tool is helping women with breast cancer weigh up the options of breast reconstruction after a mastectomy. Kate Gale with her children Bree and Gemma when she was ambassador for the Mother’s Day Classic in 2014.

Serendipity lead the local charge

Serendipity President and cancer survivor Liney Manning believes that a full time nurse would compliment “the best cancer centre in the southern hemisphere”. Collecting support: Sandy Brooks, Liney Manning , with Ruth Campbell, Helen Tickle, Caroline Wright and Adele Holtsbaum.

UK agency says Pfizer breast cancer drug too expensive

Pfizer’s breast cancer drug Ibrance, or palbociclib, is too expensive to justify its use on Britain’s state-run health service, the country’s healthcare cost-effectiveness watchdog said on Friday. The logo of Dow Jones Industrial Average stock market index listed company Pfizer is pictured here in La Jolla, California April 21, 2016.

Breast Density May Be Leading Indicator of Cancer Risk

Women whose breasts are predominantly made up of more dense, glandular tissue face higher odds for breast cancer, a new study finds. The researchers added that, based on their study of 200,000 women, breast density may be the most important gauge of breast cancer risk, eclipsing family history of the disease and other risk factors.

Breast density may be leading indicator of cancer risk

Women whose breasts are predominantly made up of more dense, glandular tissue face higher odds for breast cancer, a new study finds. The researchers added that, based on their study of 200,000 women, breast density may be the most important gauge of breast cancer risk, eclipsing family history of the disease and other risk factors.

Keep drugs

IT is devastating to hear that Kadcyla – a crucial life-extending treatment for women with incurable secondary breast cancer – faces being withdrawn from the NHS following the failure of NICE and the drug’s manufacturer Roche to reach an agreement. Kadcyla can offer patients precious extra months – even years – of good quality time with their loved ones, with fewer side effects than through other treatments.

Does expecting more pain make it more intense? Factors associated…

Does expecting more pain make it more intense? Factors associated with the first week pain trajectories after breast cancer surgery. The aim of this study was to identify clinical risk factors for unfavorable pain trajectories after breast cancer surgery in order to better understand the association between pain expectation, psychological distress, and acute postoperative pain.

Roche profit rises on drug, diagnostic tool sales

Roche Holding AG said profit climbed in 2016, as several of its top-selling drugs continued to prosper amid less generic competition than those of the Swiss pharmaceutical giant’s rivals. The company posted net profit of 9.6 billion Swiss francs for 2016, 8% higher than a year earlier.

Ulster boy has ‘The Power’ on his side in cancer battle

A nine-year-old boy undergoing intense cancer treatment has been boosted by the support of a number of high-profile darts players. Phil ‘The Power’ Taylor is among those who have donated shirts which will be auctioned to raise funds for the respite care of Lurgan boy Jack Roycroft who faces a long period of chemotherapy and radiotherapy having had a tumour removed from his kidney before Christmas.

vacuum sucks away breast cancer tumour

A British hospital has made history by becoming the first in the world to remove a cancerous breast tumour under local anaesthetic using a vacuum. It is the first time ever the innovative non-surgical procedure has been used to treat a malignant breast cancer tumour.

Drugs firms profiteer from NHS by hiking cancer drugs prices

Drug companies are profiteering from the NHS to the tune of 1 billion because they have unjustifiably hiked prices of cancer medicine, experts warn. Cancer patients are let down by greedy drug companies who delay availability of well-established treatments and raise the prices beyond what the NHS can afford, academics said.

Global Breast Health & Wellness Center Expands Use of Cryoablation…

Dr. April L. Speed, first in Georgia to provide cryoablation for early stage breast cancer with the Visica 2 Treatment System Global Breast Health & Wellness Center, founded by Dr. April Speed, announced it has expanded its cryoablation treatment of fibroadenoma to include early stage breast cancer with the Visica 2 Treatment System. Developed by Sanarus Technologies, the Visica 2 Treatment System is a cryoablation device that uses extreme cold liquid nitrogen to destroy tissue .

3 Biotech Stocks I’d Buy Right Now

Despite the sway of political uncertainty for the biotechnology industry at the moment, these three stocks look like great buys right now. Conflicting statements from the Trump administration have made owning biotech stocks feel like a roller-coaster ride in recent weeks, but there are a few stocks I’d happily buy and hold despite the sway of political uncertainty.